Johnson & Johnson Files For Emergency Authorization For Its Coronavirus Vaccine

Fight Censorship, Share This Post!

Johnson & Johnson filed for emergency use authorization from the FDA on Thursday for its coronavirus vaccine.

The drug maker’s application followed its announcement that its vaccine was 72% effective in combating the virus. Although that’s slightly lower than Pfizer and Moderna’s vaccines, Johnson & Johnson’s requires one dose instead of two.


Fight Censorship, Share This Post!

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.